0001209191-19-044837.txt : 20190806
0001209191-19-044837.hdr.sgml : 20190806
20190806164329
ACCESSION NUMBER: 0001209191-19-044837
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190805
FILED AS OF DATE: 20190806
DATE AS OF CHANGE: 20190806
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 191002714
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-05
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CL&AO
Common Stock
2019-08-05
4
M
0
2330
86.52
A
37333
D
Common Stock
2019-08-05
4
S
0
700
174.74
D
36633
D
Common Stock
2019-08-05
4
S
0
1630
175.51
D
35003
D
Stock Option (Right to Buy)
86.52
2019-08-05
4
M
0
2330
0.00
A
2027-02-02
Common Stock
2330
13980
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $174.74 (range $174.19 to $175.01).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $175.51 (range $175.07 to $176.04).
The option vests in 16 quarterly installments from 2/3/2017.
/s/ Omar White, Attorney-in-Fact
2019-08-06